Investigational Site Number 246005

Kuopio 70210

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin — Completed
• Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients — Completed